Next Article in Journal
Evaluation of Two-Diabetes Related microRNAs Suitability as Earlier Blood Biomarkers for Detecting Prediabetes and type 2 Diabetes Mellitus
Next Article in Special Issue
Outcomes for Women with Gestational Diabetes Treated with Metformin: A Retrospective, Case-Control Study
Previous Article in Journal
Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
Previous Article in Special Issue
Association of Maternal Factors with Perinatal Complications in Pregnancies Complicated with Diabetes: A Single-Center Retrospective Analysis
Open AccessReview

Controversies and Advances in Gestational Diabetes—An Update in the Era of Continuous Glucose Monitoring

Laboratory of Endocrinology, Federal University of Minas Gerais, Belo Horizonte 30130-100, Brazil
Author to whom correspondence should be addressed.
J. Clin. Med. 2018, 7(2), 11;
Received: 19 November 2017 / Revised: 8 January 2018 / Accepted: 9 January 2018 / Published: 25 January 2018
(This article belongs to the Special Issue Therapeutic Strategies for Diabetes in Pregnancy)
Diabetes in pregnancy, both preexisting type 1 or type 2 and gestational diabetes, is a highly prevalent condition, which has a great impact on maternal and fetal health, with short and long-term implications. Gestational Diabetes Mellitus (GDM) is a condition triggered by metabolic adaptation, which occurs during the second half of pregnancy. There is still a lot of controversy about GDM, from classification and diagnosis to treatment. Recently, there have been some advances in the field as well as recommendations from international societies, such as how to distinguish previous diabetes, even if first recognized during pregnancy, and newer diagnostic criteria, based on pregnancy outcomes, instead of maternal risk of future diabetes. These new recommendations will lead to a higher prevalence of GDM, and important issues are yet to be resolved, such as the cost-utility of this increase in diagnoses as well as the determinants for poor outcomes. The aim of this review is to discuss the advances in diagnosis and classification of GDM, as well as their implications in the field, the issue of hyperglycemia in early pregnancy and the role of hemoglobin A1c (HbA1c) during pregnancy. We have looked into the determinants of the poor outcomes predicted by the diagnosis by way of oral glucose tolerance tests, highlighting the relevance of continuous glucose monitoring tools, as well as other possible pathogenetic factors related to poor pregnancy outcomes. View Full-Text
Keywords: gestational diabetes; diagnosis; inflammation; lipids; birth weight; glucose gestational diabetes; diagnosis; inflammation; lipids; birth weight; glucose
Show Figures

Figure 1

MDPI and ACS Style

Carreiro, M.P.; Nogueira, A.I.; Ribeiro-Oliveira, A. Controversies and Advances in Gestational Diabetes—An Update in the Era of Continuous Glucose Monitoring. J. Clin. Med. 2018, 7, 11.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop